Neoadjuvant Treatment in Locally Advanced Thyroid Carcinoma.
1/5 보강
Although the focus in the last decades has been on the overdiagnosis of incidentally detected thyroid carcinomas in early stages, the other extreme of the disease is represented by locally advanced tu
APA
Navas Moreno V, Sebastián Valles F, et al. (2024). Neoadjuvant Treatment in Locally Advanced Thyroid Carcinoma.. Journal of clinical medicine, 13(19). https://doi.org/10.3390/jcm13195769
MLA
Navas Moreno V, et al.. "Neoadjuvant Treatment in Locally Advanced Thyroid Carcinoma.." Journal of clinical medicine, vol. 13, no. 19, 2024.
PMID
39407830 ↗
Abstract 한글 요약
Although the focus in the last decades has been on the overdiagnosis of incidentally detected thyroid carcinomas in early stages, the other extreme of the disease is represented by locally advanced tumors with the invasion of neighboring structures. These are infrequent tumors, but they have a high complexity and a poor prognosis. In the absence of effective therapies allowing preoperative tumor reduction, in order to achieve a more restricted surgery, treatment was limited to aggressive surgery with resection of the aerodigestive tract and major vascular structures or palliative treatment. However, due to the increased knowledge of tumor biology and the results that tyrosine kinase inhibitors have achieved in the treatment of radioactive iodine-refractory tumors, neoadjuvant therapy with a curative intent has emerged as a reality to be taken into account when dealing with these patients. This paper presents a narrative review of the current scientific evidence regarding neoadjuvant treatment in locally advanced thyroid cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Complete Pathological Response to Neoadjuvant Cisplatin, Etoposide, and Pembrolizumab in Small Cell Breast Carcinoma: A Case Report and Review of the Literature.
- Artificial Intelligence and Prostate-Breast Cancer Biology: Recent Advances in Treatments and Perspectives - A Comprehensive Review.
- Editorial: Treatment response and resistance to targeted therapies for NSCLC.
- Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma.
- Layers of Hope: How Graphene and Nanostructures Hold Promise for Cancer Therapy.
- Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently.